GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
82.90
+1.06 (1.30%)
Nov 13, 2026, 3:47 PM EST - Market open
GEHC Revenue
GE HealthCare Technologies had revenue of $5.51B in the quarter ending September 30, 2026, with 7.19% growth. This brings the company's total for the last twelve months to $21.64B, up 6.87% year-over-year. In the year 2025, GE HealthCare Technologies had annual revenue of $20.63B with 4.84% growth. That makes GE HealthCare Technologies the 703rd largest company in the world by revenue and 236th in the United States.
Revenue (ttm)
$21.64B
Revenue Growth
+6.87%
P/S Ratio
1.73
Revenue / Employee
$400,685
Employees
54,000
Market Cap
37.48B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full GEHC breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.63B | 953.00M | 4.84% |
| Dec 31, 2024 | 19.67B | 120.00M | 0.61% |
| Dec 31, 2023 | 19.55B | 1.21B | 6.60% |
| Dec 31, 2022 | 18.34B | 756.00M | 4.30% |
| Dec 31, 2021 | 17.59B | 421.00M | 2.45% |
| Dec 31, 2020 | 17.16B | 531.00M | 3.19% |
| Dec 31, 2019 | 16.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medtronic | 37.54B |
| Stryker | 26.30B |
| Boston Scientific | 21.07B |
| Koninklijke Philips | 20.16B |
| Zimmer Biomet Holdings | 8.57B |
| Edwards Lifesciences | 6.67B |
| Smith & Nephew | 6.30B |
| STERIS | 6.17B |
GEHC News
- 2 days ago - GE HealthCare price target raised to $110 from $85 at Argus - TheFly
- 3 days ago - GE HealthCare announces intent to establish MAGNUS Neuro Alliance - TheFly
- 3 days ago - GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience - Business Wire
- 10 days ago - GE HealthCare announces two new AI-assisted capabilities for Vscan Air - TheFly
- 10 days ago - GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments - Business Wire
- 10 days ago - GE HealthCare price target raised to $80 from $73 at UBS - TheFly
- 12 days ago - GE HealthCare introduces Allia Celeo, an image guiding system - TheFly
- 12 days ago - GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging - Business Wire